Olema Pharmaceuticals
Stock Forecast, Prediction & Price Target

Olema Pharmaceuticals Financial Estimates

Olema Pharmaceuticals Revenue Estimates

Olema Pharmaceuticals EBITDA Estimates

Olema Pharmaceuticals Earnings per Share Estimates

Passed Analyst forecast
Metric 12/31/2021 12/31/2022 12/31/2023 12/31/2025 12/31/2026 12/31/2027 12/31/2028
Revenue
 
% change YoY
$0
 
N/A
$0
 
0%
$0
 
0%
Avg: $0
Low: $0
High: $0
avg. 0%
Avg: $5.83M
Low: $5.83M
High: $5.83M
avg. 0%
Avg: $34.91M
Low: $34.91M
High: $34.91M
avg. 498.24%
Avg: $283.12M
Low: $283.12M
High: $283.12M
avg. 710.93%
Net Income
 
% change YoY
$-70.88M
 
N/A
$-102.58M
 
-44.71%
$-96.65M
 
5.78%
Avg: $-159.69M
Low: $-144.02M
High: $-91.39M
avg. -65.21%
Avg: $-175.94M
Low: $-142.52M
High: $-90.49M
avg. -10.17%
Avg: $-113.87M
Low: $-113.87M
High: $-113.87M
avg. 35.27%
Avg: $6.63M
Low: $6.63M
High: $6.63M
avg. 105.82%
EBITDA
 
% change YoY
$-71.09M
 
N/A
$-106.98M
 
-50.48%
$-104.58M
 
2.24%
Avg: $0
Low: $0
High: $0
avg. 100%
Avg: $0
Low: $0
High: $0
avg. 0%
Avg: $0
Low: $0
High: $0
avg. 0%
Avg: $0
Low: $0
High: $0
avg. 0%
EPS
 
% change YoY
-$1.79
 
N/A
-$2.56
 
-43.01%
-$2.14
 
16.40%
Avg: -$2.53
Low: -$3.18
High: -$2.02
avg. -18.17%
Avg: -$2.65
Low: -$3.15
High: -$2
avg. -4.91%
Avg: -$2.52
Low: -$2.52
High: -$2.52
avg. 5.14%
Avg: $0.15
Low: $0.15
High: $0.15
avg. 105.82%
Operating Expenses
 
% change YoY
$71.49M
 
N/A
$106.98M
 
49.65%
$104.96M
 
-1.89%
Avg: $0
Low: $0
High: $0
avg. -100%
Avg: $0
Low: $0
High: $0
avg. 0%
Avg: $0
Low: $0
High: $0
avg. 0%
Avg: $0
Low: $0
High: $0
avg. 0%

FAQ

What is Olema Pharmaceuticals stock earnings growth forecast?

Wall Street analysts estimate the annual average earnings growth rate of 16.42% in 2025-2028.

We have gathered data from 6 analysts. Their low estimate is -144.02M, average is -159.69M and high is -91.39M.

What is Olema Pharmaceuticals stock revenue growth forecast?

Wall Street analysts forecast annual average revenue growth of 302.29% in 2025-2028.

We have gathered data from 6 analysts. Their low revenue estimate is N/A, average is N/A and high is N/A.

What is Olema Pharmaceuticals stock earnings per share growth forecast?

Wall Street analysts forecast annual average earnings growth of 21.97% in 2025-2028.

We have gathered data from 6 analysts. Their low earnings per share estimate is -$3.18, average is -$2.53 and high is $-2.02.

What is the best performing analyst?

In the last twelve months analysts have been covering Olema Pharmaceuticals stock. The most successful analyst is Richard Law.